[{"address1": "55 Claverick Street", "address2": "Room 325", "city": "Providence", "state": "RI", "zip": "02903", "country": "United States", "phone": "401 444 7375", "website": "https://www.oceanbiomedical.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment of idiopathic pulmonary fibrosis (IPF) and hermansky-pudlak syndrome (HPS). The company's infectious diseases product candidates for malaria include the ODA-570 vaccine for the prevention of P. falciparum infection; ODA-611 anti-PfGARP mAb for the treatment of Symptomatic P. falciparum infection; and ODA-579 anti-PfGARP small molecule for the treatment of Symptomatic P. falciparum infection. It has license agreement with Elkurt, Inc. for FRG Antibody, bi-specific antibody anti-CTLA4, bispecific (FRG)x anti-PD-1 (FRGxPD-1), chit1 small molecule antifibrotic, and malaria small molecules and antibodies. The company was founded in 2019 and is based in Providence, Rhode Island. Ocean Biomedical, Inc. is a subsidiary of Poseidon Bio, LLC.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Inderjote  Kathuria M.B.A., M.D.", "age": 57, "title": "Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.", "age": 59, "title": "Founder & Executive Chairman of the Board", "yearBorn": 1966, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jolie G. Kahn CPA, Esq.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0017, "open": 0.0005, "dayLow": 0.0005, "dayHigh": 0.0007, "regularMarketPreviousClose": 0.0017, "regularMarketOpen": 0.0005, "regularMarketDayLow": 0.0005, "regularMarketDayHigh": 0.0007, "payoutRatio": 0.0, "beta": 1.494, "forwardPE": -0.0015730336, "volume": 7780, "regularMarketVolume": 7780, "averageVolume": 175676, "averageVolume10days": 106036, "averageDailyVolume10Day": 106036, "bid": 0.0057, "ask": 0.0069, "bidSize": 14997, "askSize": 333442, "marketCap": 325311, "fiftyTwoWeekLow": 1e-05, "fiftyTwoWeekHigh": 0.1628, "allTimeHigh": 26.6015, "allTimeLow": 1e-05, "fiftyDayAverage": 0.000944, "twoHundredDayAverage": 0.004314, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "profitMargins": 0.0, "floatShares": 208405973, "sharesOutstanding": 232365143, "sharesShort": 2930195, "sharesShortPriorMonth": 5719851, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0177, "heldPercentInsiders": 0.10311, "heldPercentInstitutions": 0.0, "shortRatio": 0.05, "shortPercentOfFloat": 0.020499999, "impliedSharesOutstanding": 232365143, "bookValue": -0.557, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -30719000, "trailingEps": -0.91, "forwardEps": -0.89, "52WeekChange": -0.99013656, "SandP52WeekChange": 0.11527538, "quoteType": "EQUITY", "currentPrice": 0.0014, "recommendationKey": "none", "totalDebt": 15352000, "currentRatio": 0.056, "returnOnAssets": -1.14869, "freeCashflow": -5344625, "operatingCashflow": -4051000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OCEA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchange": "PNK", "messageBoardId": "finmb_669640055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "regularMarketChangePercent": -17.647062, "regularMarketPrice": 0.0014, "marketState": "CLOSED", "shortName": "Ocean Biomediacal, Inc.", "longName": "Ocean Biomedical, Inc.", "fiftyTwoWeekHighChangePercent": -0.99140054, "fiftyTwoWeekChangePercent": -99.01366, "earningsTimestampStart": 1744115400, "earningsTimestampEnd": 1744115400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.91, "epsForward": -0.89, "fiftyDayAverageChange": 0.00045599992, "fiftyDayAverageChangePercent": 0.48305076, "twoHundredDayAverageChange": -0.0029139998, "twoHundredDayAverageChangePercent": -0.6754752, "priceToBook": -0.002513465, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1770325200, "ipoExpectedDate": "2021-07-30", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1676471400000, "regularMarketChange": -0.00030000007, "regularMarketDayRange": "5.0E-4 - 7.0E-4", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 175676, "fiftyTwoWeekLowChange": 0.00139, "fiftyTwoWeekLowChangePercent": 139.0, "fiftyTwoWeekRange": "1.0E-5 - 0.1628", "fiftyTwoWeekHighChange": -0.1614, "market": "us_market", "esgPopulated": false, "displayName": "Ocean Biomedical", "trailingPegRatio": null, "__fetch_time": "2026-02-21"}]